Anxiety Disorders and Prediction of Their Development in Patients with Hypothyroidism and Autoimmune Thyroiditis

Iryna Kamyshna; Larysa Pavlovych; Volodymyr Pankiv; Ivan Pankiv; Aleksandr Kamyshnyi

doi:10.3889/oamjms.2022.9746

Authors

Iryna Kamyshna Department of Medical Rehabilitation, I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine
Larysa Pavlovych Department of Clinical Immunology, Allergology and Endocrinology, HSEEU “Bukovinian State Medical University”, Chernivtsi, Ukraine
Volodymyr Pankiv Department of Clinical Endocrinology, Ukrainian Research and Practical Center for Endocrine Surgery, Transplantation of Endocrine Organs and Tissues, Ministry of Health, Kyiv, Ukraine
Ivan Pankiv Department of Clinical Immunology, Allergology and Endocrinology, HSEEU “Bukovinian State Medical University”, Chernivtsi, Ukraine;
Aleksandr Kamyshnyi Department of Microbiology, Virology and Immunology, I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine

DOI:

https://doi.org/10.3889/oamjms.2022.9746

Keywords:

BDNF, VDR, NMDA, Anxiety, Autoimmune thyroiditis, Hypothyroidism

Abstract

Objective: Since the association between thyroid dysfunction and neuropsychiatric disorders has been known for many years, it is important to analyze the associations of the BDNF gene polymorphism (rs6265), the VDR gene polymorphism (rs2228570), and the NMDA gene polymorphism (rs4880213) with the anxiety in patients with autoimmune thyroiditis and hypothyroidism in the Western Ukrainian population and predict the development of anxiety disorders in these patients.

Methods: The study involved a total of 153 patients with various forms of thyroid pathology. BDNF levels in the sera of the patients and healthy individuals were quantified using an enzyme-linked immunosorbent assay with a highly sensitive Human BDNF ELISA Kit (Elabscience®, United States, Catalog No: E-EL-H0010) on E.I.A. Reader Sirio S (Seac, Italy). Genotyping of the VDR (rs2228570), BDNF (rs6265), and NMDA (rs4880213) gene polymorphism using TaqMan probes and TaqMan Genotyping Master Mix (4371355) on CFX96™Real-Time PCR Detection System (Bio-Rad Laboratories, Inc., USA). Polymerase chain reaction (PCR) for TaqMan genotyping was carried out according to the kit instructions (Applied Biosystems, USA).

Results: According to the data obtained when comparing the presence of anxiety on the Hamilton scale on SNP statistically significant differences were revealed depending on BDNF gene polymorphism (rs6265) (p < 0.001). When comparing the presence of anxiety on the Hamilton scale on SNP depending on VDR gene polymorphism (rs2228570), NMDA gene polymorphism (rs4880213) no statistically significant differences were revealed (p = 0.782, p = 0.677 respectively) We identified an inverse strong correlation between the presence of anxiety on Hamilton scale and BDNF, 25-OH Vitamin D levels, and fT4 in the blood (p <0.001) and a direct moderate correlation between the presence of anxiety on Hamilton scale and TSH, GRIN2B, and anti-TPO (p <0.001).

Conclusion: Indicators such as BDNF, GRIN2B, fT4, anti-TG, and 25-OH levels of vitamin D are prognostically significant risk criteria for anxiety.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Caturegli P, De Remigis A, Rose NR. Hashimoto thyroiditis: Clinical and diagnostic criteria. Autoimmun Rev. 2014;13(4-5):391-7. https://doi.org/10.1016/j.autrev.2014.01.007 PMid:24434360 DOI: https://doi.org/10.1016/j.autrev.2014.01.007

Bauer M, Goetz T, Glenn T, Whybrow PC. The thyroidbrain interaction in thyroid disorders and mood disorders. J Neuroendocrinol. 2008;20(10):1101-14. https://doi.org/10.1111/j.1365-2826.2008.01774.x PMid:18673409 DOI: https://doi.org/10.1111/j.1365-2826.2008.01774.x

Leyhe T, Müssig K. Cognitive and affective dysfunctions in autoimmune thyroiditis. Brain Behav Immun. 2014;41:261-6. https://doi.org/10.1016/j.bbi.2014.03.008 PMid:24685840 DOI: https://doi.org/10.1016/j.bbi.2014.03.008

Casseb GA, Kaster MP, Rodrigues AL. Potential role of Vitamin D for the management of depression and anxiety. CNS Drugs. 2019;33(7):619-37. https://doi.org/10.1007/s40263-019-00640-4 PMid:31093951 DOI: https://doi.org/10.1007/s40263-019-00640-4

Fischer S, Ehlert U. Hypothalamic-pituitary-thyroid (HPT) axis functioning in anxiety disorders. A systematic review. Depress Anxiety. 2018;35(1):98-110. https://doi.org/10.1002/da.22692 PMid:29064607 DOI: https://doi.org/10.1002/da.22692

Zherebiatiev A, Kamyshnyi A. Expression levels of proinflammatory cytokines and NLRP3 inflammasome in an experimental model of oxazolone-induced colitis. Iran J Allergy Asthma Immunol. 2016;15(1):39-45. PMid:26996110.

Putilin D, Kamyshnyi A. Сhanges of Glut1, mTOR and AMPK1α gene expression in pancreatic lymph node lymphocytes of rats with experimental diabetes mellitus. Med Immunol. 2016;18(4):339-46. https://doi.org/10.15789/1563-0625-2016-4-339-346 DOI: https://doi.org/10.15789/1563-0625-2016-4-339-346

Nosulenko IS, Voskoboynik YU, Berest GG, Safronyuk SL, Kovalenko SI, Kamyshnyi OM, et al. Synthesis and antimicrobial activity of 6-Thioxo-6,7-dihydro-2H-[1,2,4]triazino [2,3-c]- quinazolin-2-one derivatives. Sci Pharm. 2014;82(3):483-500. https://doi.org/10.3797/scipharm.1402-10 PMid:25853063 DOI: https://doi.org/10.3797/scipharm.1402-10

Topol IA, Kamyshny AM, Abramov AV, Kolesnik YM. Expression of XBP1 in lymphocytes of the small intestine in rats under chronic social stress and modulation of intestinal microflora composition. Fiziol Zh. 2014;60(2):38-44. https://doi.org/10.15407/fz60.02.038 PMid:25007519 DOI: https://doi.org/10.15407/fz60.02.038

Topol I, Kamyshny A. Study of expression of TLR2, TLR4 and transckription factor NF-kB structures of galt of rats in the conditions of the chronic social stress and modulation of structure of intestinal microflora. Georgian Med News. 2013;(225):115-22. PMid:24423688.

Bilous II, Pavlovych LL, Kamyshnyi AM. Primary hypothyroidism and autoimmune thyroiditis alter the transcriptional activity of genes regulating neurogenesis in the blood of patients. Endocr Regul. 2021;55(1):5-15. https://doi.org/10.2478/enr-2021-0002 PMid:33600668 DOI: https://doi.org/10.2478/enr-2021-0002

Kamyshna I, Kamyshnyi A. Transcriptional activity of neurotrophins genes and their receptors in the peripheral blood in patients with thyroid diseases in Bukovinian population of Ukraine. Open Access Maced J Med Sci. 2021;9(A):208-16. https://doi.org/10.3889/oamjms.2021.6037 DOI: https://doi.org/10.3889/oamjms.2021.6037

Bilous II, Korda MM, Krynytska IY, Kamyshnyi AM. Nerve impulse transmission pathway-focused genes expression analysis in patients with primary hypothyroidism and autoimmune thyroiditis. Endocr Regul. 2020;54(2):109-18. https://doi.org/10.2478/enr-2020-0013 PMid:32597152 DOI: https://doi.org/10.2478/enr-2020-0013

Bilous I, Pavlovych L, Krynytska I, Marushchak M, Kamyshnyi A. Apoptosis and cell cycle pathway-focused genes expression analysis in patients with different forms of thyroid pathology. Open Access Maced J Med Sci. 2020;8(B):784-92. https://doi.org/10.3889/oamjms.2020.4760 DOI: https://doi.org/10.3889/oamjms.2020.4760

Kamyshna I, Pavlovych L, Kamyshnyi A. Association between serum brain-derived neurotrophic factor and 25-oh vitamin d levels with Vitamin D receptors gene polymorphism (rs2228570) in patients with autoimmune thyroiditis and hypothyroidism. Open Access Maced J Med Sci. 2021;9(A):659-64. https://doi.org/10.3889/oamjms.2021.6631 DOI: https://doi.org/10.3889/oamjms.2021.6631

Kamyshna I, Pavlovych L, Malyk I, Kamyshnyi A. 25-OH Vitamin D blood serum linkage with VDR gene polymorphism (rs2228570) in thyroid pathology patients in the West-Ukrainian population. J Med Life. 2021;14(4):549-56. https://doi.org/10.2478/enr-2021-0021 PMid:34621381

Kamyshna I, Pavlovych L, Maslyanko V, Kamyshnyi A. Analysis of the transcriptional activity of genes of neuropeptides and their receptors and their receptors in the blood of patients with thyroid pathology. J Med Life. 2021;14(2):243-49. https://doi.org/10.25122/jml-2020-0183 PMid:34104248 DOI: https://doi.org/10.25122/jml-2020-0183

Kamyshna I, Pavlovych L, Sydorchuk L, Malyk I, Kamyshnyi A. BDNF blood serum linkage with BDNF gene polymorphism (rs6265) in thyroid pathology patients in the West-Ukrainian population. Endocr Regul. 2021;55(4):101-11. https://doi.org/10.2478/enr-2021-0021 PMid:34879183 DOI: https://doi.org/10.2478/enr-2021-0021

Garber JR, Cobin RH, Gharib H, Hennessey JV, Klein I, Mechanick JI, et al. Clinical practice guidelines for hypothyroidism in adults: Cosponsored by the American association of clinical endocrinologists and the American thyroid association. Endocr Pract. 2012;18(6):988-1028. https://doi.org/10.4158/ep12280.gl PMid:23246686 DOI: https://doi.org/10.4158/EP12280.GL

Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32(1):50-5. https://doi.org/10.1111/j.2044-8341.1959.tb00467.x PMid:13638508 DOI: https://doi.org/10.1111/j.2044-8341.1959.tb00467.x

Matza LS, Morlock R, Sexton C, Malley K, Feltner D. Identifying HAM-A cutoffs for mild, moderate, and severe generalized anxiety disorder. Int J Methods Psychiatr Res. 2010;19(4):223-32. https://doi.org/10.1002/mpr.323 PMid:20718076 DOI: https://doi.org/10.1002/mpr.323

Ittermann T, Völzke H, Baumeister SE, Appel K, Grabe HJ. Diagnosed thyroid disorders are associated with depression and anxiety. Soc Psychiatry Psychiatr Epidemiol. 2015;50(9):1417-25. https://doi.org/10.1007/s00127-015-1043-0 PMid:25777685 DOI: https://doi.org/10.1007/s00127-015-1043-0

Siegmann EM, Müller HH, Luecke C, Philipsen A, Kornhuber J, Grömer TW. Association of depression and anxiety disorders with autoimmune thyroiditis: A systematic review and Metaanalysis. JAMA Psychiatry. 2018;75(6):577-84. https://doi.org/10.1001/jamapsychiatry.2018.0190 PMid:29800939 DOI: https://doi.org/10.1001/jamapsychiatry.2018.0190

Bandelow B, Lichte T, Rudolf S, Wiltink J, Beutel ME. The diagnosis of and treatment recommendations for anxiety disorders. Dtsch Arztebl Int. 2014;111(27-28):473-80. https://doi.org/10.3238/arztebl.2014.0473 PMid:25138725 DOI: https://doi.org/10.3238/arztebl.2014.0473

Yalcin MM, Altinova AE, Cavnar B, Bolayir B, Akturk M, Arslan E, et al. Is thyroid autoimmunity itself associated with psychological well-being in euthyroid Hashimoto’s thyroiditis? Endocr J. 2017;64(4):425-29. https://doi.org/10.1507/endocrj.ej16-0418 PMid:28260699 DOI: https://doi.org/10.1507/endocrj.EJ16-0418

Panicker V, Evans J, Bjøro T, Åsvold BO, Dayan CM, Bjerkeset O. A paradoxical difference in relationship between anxiety, de- pression and thyroid function in subjects on and not on T4: Findings from the HUNT study. Clin Endocrinol (Oxf). 2009;71(4):574-80. https://doi.org/10.1111/j.1365-2265.2008.03521.x PMid:19751298 DOI: https://doi.org/10.1111/j.1365-2265.2008.03521.x

Fu X, Wang J, Du J, Sun J, Baranova A, Zhang F. BDNF gene’s role in schizophrenia: From risk allele to methylation implications. Front Psychiatry. 2020;11:564277. https://doi.org/10.3389/fpsyt.2020.564277 PMid:33384622 DOI: https://doi.org/10.3389/fpsyt.2020.564277

Rios M, Fan G, Fekete C, Kelly J, Bates B, Kuehn R, et al. Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. Mol Endocrinol. 2001;15(10):1748-57. https://doi.org/10.1210/mend.15.10.0706 PMid:11579207 DOI: https://doi.org/10.1210/mend.15.10.0706

Chen ZY, Jing D, Bath KG, Ieraci A, Khan T, Siao CJ, et al. Genetic variant BDNF (Val66Met) polymorphism alters anxietyrelated behavior. Science. 2006;314(5796):140-3. https://doi.org/10.1126/science.1129663 PMid:17023662 DOI: https://doi.org/10.1126/science.1129663

Hall D, Dhilla A, Charalambous A, Gogos JA, Karayiorgou M. Sequence variants of the brain-derived neurotrophic factor (BDNF) gene are strongly associated with obsessivecompulsive disorder. Am J Hum Genet. 2003;73(2):370-6. https://doi.org/10.1086/377003 PMid:12836135 DOI: https://doi.org/10.1086/377003

Katerberg H, Lochner C, Cath DC, de Jonge P, Bochdanovits Z, Moolman-Smook JC, et al. The role of the brain-derived neurotrophic factor (BDNF) val66met variant in the phenotypic expression of obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet. 2009;150B(8):1050-62. https://doi.org/10.1002/ajmg.b.30930 PMid:19219856 DOI: https://doi.org/10.1002/ajmg.b.30930

Wendland JR, Kruse MR, Cromer KR, Murphy DL. A large casecontrol study of common functional SLC6A4 and BDNF variants in obsessive-compulsive disorder. Neuropsychopharmacology. 2007;32(12):2543-51. https://doi.org/10.1038/sj.npp.1301394 PMid:17375136 DOI: https://doi.org/10.1038/sj.npp.1301394

Hemmings SM, Kinnear CJ, Van der Merwe L, Lochner C, Corfield VA, Moolman-Smook JC, et al. Investigating the role of the brain-derived neurotrophic factor (BDNF) val66met variant in obsessive-compulsive disorder (OCD). World J Biol Psychiatry. 2008;9(2):126-34 https://doi.org/10.1080/15622970701245003 PMid:17853300 DOI: https://doi.org/10.1080/15622970701245003

Rocha FF, Malloy-Diniz L, Lage NV, Corrêa H. Positive association between MET allele (BDNF Val66Met polymorphism) and obsessive-compulsive disorder. Braz J Psychiatry. 2010;32(3):323-4. https://doi.org/10.1590/s1516-44462010000300023 PMid:20945028 DOI: https://doi.org/10.1590/S1516-44462010000300023

Frustaci A, Pozzi G, Gianfagna F, Manzoli L, Boccia S. Metaanalysis of the brain-derived neurotrophic factor gene (BDNF) Val66Met polymorphism in anxiety disorders and anxiety-related personality traits. Neuropsychobiology. 2008;58(3-4):163-70. https://doi.org/10.1159/000182892 PMid:19088493 DOI: https://doi.org/10.1159/000182892

Zhang H, Ozbay F, Lappalainen J, Kranzler HR, van Dyck CH, Charney DS, et al. Brain derived neurotrophic factor (BDNF) gene variants and Alzheimer’s disease, affective disorders, posttraumatic stress disorder, schizophrenia, and substance dependence. Am J Med Genet B Neuropsychiatr Genet. 2006;141B(4):387-93. https://doi.org/10.1002/ajmg.b.30332 PMid:16649215 DOI: https://doi.org/10.1002/ajmg.b.30332

Lam P, Cheng CY, Hong CJ, Tsai SJ. Association study of a brainderived neurotrophic factor (Val66Met) genetic polymorphism and panic disorder. Neuropsychobiology. 2004;49(4):178-81. https://doi.org/10.1159/000077362 PMid:15118353 DOI: https://doi.org/10.1159/000077362

Che MH, Tsai SJ. Treatment-resistant panic disorder: Clinical significance, concept and management. Prog Neuropsychopharmacol Biol Psychiatry. 2016;70:219-26. https://doi.org/10.1016/j.pnpbp.2016.02.001 PMid:26850787 DOI: https://doi.org/10.1016/j.pnpbp.2016.02.001

Chen K, Wang N, Zhang J, Hong X, Xu H, Zhao X, et al. Is the Val66Met polymorphism of the brain-derived neurotrophic factor gene associated with panic disorder? A meta-analysis. Asia Pac Psychiatry. 2017;9(2):e12228. https://doi.org/10.1111/appy.12228 PMid:26687639 DOI: https://doi.org/10.1111/appy.12228

Davis M, Walker DL, Miles L, Grillon C. Phasic vs sustained fear in rats and humans: Role of the extended amygdala in fear vs anxiety. Neuropsychopharmacology. 2010;35(1):105-35. https://doi.org/10.1038/npp.2009.109 PMid:19693004 DOI: https://doi.org/10.1038/npp.2009.109

Armstrong DJ, Meenagh GK, Bickle I, Lee AS, Curran ES, Finch MB. Vitamin D deficiency is associated with anxiety and depression in fibromyalgia. Clin Rheumatol. 2007;26(4):551-4. https://doi.org/10.1007/s10067-006-0348-5 PMID: 16850115. DOI: https://doi.org/10.1007/s10067-006-0348-5

Black LJ, Jacoby P, Allen KL, Trapp GS, Hart PH, Byrne SM, et al. Low Vitamin D levels are associated with symptoms of depression in young adult males. Aust N Z J Psychiatry. 201;48(5):464-71. https://doi.org/10.1177/0004867413512383 PMid:24226892 DOI: https://doi.org/10.1177/0004867413512383

Bičíková M, Dušková M, Vítků J, Kalvachová B, Řípová D, Mohr P, et al. Vitamin D in anxiety and affective disorders. Physiol Res. 2015;64(Suppl 2):S101-3. https://doi.org/10.33549/physiolres.933082 PMid:26680471 DOI: https://doi.org/10.33549/physiolres.933082

Choukri MA, Conner TS, Haszard JJ, Harper MJ, Houghton LA. Effect of Vitamin D supplementation on depressive symptoms and psychological wellbeing in healthy adult women: A doubleblind randomised controlled clinical trial. J Nutr Sci. 2018;7:e23. https://doi.org/10.1017/jns.2018.14 PMid:30197783 DOI: https://doi.org/10.1017/jns.2018.14

Alavi NM, Khademalhoseini S, Vakili Z, Assarian F. Effect of Vitamin D supplementation on depression in elderly patients: A randomized clinical trial. Clin Nutr. 2019;38(5):2065-70. https://doi.org/10.1016/j.clnu.2018.09.011 PMid:30316534 DOI: https://doi.org/10.1016/j.clnu.2018.09.011

Santos P, Herrmann AP, Elisabetsky E, Piato A. Anxiolytic properties of compounds that counteract oxidative stress, neuroinflammation, and glutamatergic dysfunction: A review. Braz J Psychiatry. 2019;41(2):168-78. https://doi.org/10.1590/1516-4446-2018-0005 PMid:30328963 DOI: https://doi.org/10.1590/1516-4446-2018-0005

Lopez RB, Denny BT, Fagundes CP. Neural mechanisms of emotion regulation and their role in endocrine and immune functioning: A review with implications for treatment of affective disorders. Neurosci Biobehav Rev. 2018;95:508-14. https://doi.org/10.1016/j.neubiorev.2018.10.019 PMid:30385251 DOI: https://doi.org/10.1016/j.neubiorev.2018.10.019

DeLuca GC, Kimball SM, Kolasinski J, Ramagopalan SV, Ebers GC. Review: The role of Vitamin D in nervous system health and disease. Neuropathol Appl Neurobiol. 2013;39(5):458-84. https://doi.org/10.1111/nan.12020 PMid:23336971 DOI: https://doi.org/10.1111/nan.12020

Pankiv VI, Koval SM, Pankiv IV, Mysnychenko OV. Vitamin D status in outpatients attending the center of endocrinology. Probl Endocr Pathol. 2021;4(78):50-6. https://doi.org/10.21856/j-PEP.2021.4.07 DOI: https://doi.org/10.21856/j-PEP.2021.4.07

Pankiv V, Pankiv I. Association of Vitamin D status with body mass index in adolescents in Ukraine. Rom J Diabetes Nutr Metab Dis. 2018;25(4):377-81. https://doi.org/10.2478/rjdnmd-2018-0045 DOI: https://doi.org/10.2478/rjdnmd-2018-0045

Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010;67(5):446-57. https://doi.org/10.1016/j.biopsych.2009.09.033 PMid:20015486 DOI: https://doi.org/10.1016/j.biopsych.2009.09.033

Kayaniyil S, Vieth R, Retnakaran R, Knight JA, Qi Y, Gerstein HC, et al. Association of Vitamin D with insulin resistance and betacell dysfunction in subjects at risk for Type 2 diabetes. Diabetes Care. 2010;33(6):1379-81. https://doi.org/10.2337/dc09-2321 PMid:20215450 DOI: https://doi.org/10.2337/dc09-2321

Martin EI, Ressler KJ, Binder E, Nemeroff CB. The neurobiology of anxiety disorders: Brain imaging, genetics, and psychoneuroendocrinology. Psychiatr Clin North Am. 2009;32(3):549-75. https://doi.org/10.1016/j.psc.2009.05.004 PMid:19716990 DOI: https://doi.org/10.1016/j.psc.2009.05.004

Lee DM, Tajar A, O’Neill TW, O’Connor DB, Bartfai G, Boonen S, et al. Lower Vitamin D levels are associated with depression among community-dwelling European men. J Psychopharmacol. 2011;25(10):1320-8. https://doi.org/10.1177/0269881110379287 PMid:20823081 DOI: https://doi.org/10.1177/0269881110379287